OBJECTIVE: The present cross-sectional study evaluated the quality of life of patients treated with 3-D conformal radiotherapy for cancer of the mouth, oropharynx, hypopharynx, or larynx and investigated possible associations with clinical and sociodemographic variables using multivariate analysis. METHODS: The sample was composed of 90 patients who had completed treatment at least 3 months earlier. Data were collected from April 2016 to May 2017. The patients were clinically evaluated with regard to stimulated salivary flow, trismus, and radiation caries. Sociodemographic data and data related to the disease (stage, location of primary tumor, and radiation dose) were collected from the patient charts. Quality of life was assessed using the Brazilian version of the University of Washington Quality of Life (UW-QOL) questionnaire. Poisson logistic regression was performed to determine the mean ratio and test associations with the clinical and sociodemographic variables. RESULTS: The mean total of the UW-QOL was 814.88 (± 224.58). Patient age, staging of cancer, hyposalivation, and trismus were associated with quality of life. Patients with tumors in the advanced stage, those with hyposalivation and those with trismus respectively had 11% (CI 0.80-0.98), 12% (CI 0.79-0.99), and 15% (CI 0.77-0.94) lower UW-QOL scores, indicating poorer quality of life. CONCLUSION: Survivors of head and neck cancer experience a negative impact on quality of life associated with trismus, hyposalivation, advanced stage tumors, and a younger patient age. The present findings underscore the importance of a specific approach focused on these aspects to ensure better quality of life in the long term.
OBJECTIVE: The present cross-sectional study evaluated the quality of life of patients treated with 3-D conformal radiotherapy for cancer of the mouth, oropharynx, hypopharynx, or larynx and investigated possible associations with clinical and sociodemographic variables using multivariate analysis. METHODS: The sample was composed of 90 patients who had completed treatment at least 3 months earlier. Data were collected from April 2016 to May 2017. The patients were clinically evaluated with regard to stimulated salivary flow, trismus, and radiation caries. Sociodemographic data and data related to the disease (stage, location of primary tumor, and radiation dose) were collected from the patient charts. Quality of life was assessed using the Brazilian version of the University of Washington Quality of Life (UW-QOL) questionnaire. Poisson logistic regression was performed to determine the mean ratio and test associations with the clinical and sociodemographic variables. RESULTS: The mean total of the UW-QOL was 814.88 (± 224.58). Patient age, staging of cancer, hyposalivation, and trismus were associated with quality of life. Patients with tumors in the advanced stage, those with hyposalivation and those with trismus respectively had 11% (CI 0.80-0.98), 12% (CI 0.79-0.99), and 15% (CI 0.77-0.94) lower UW-QOL scores, indicating poorer quality of life. CONCLUSION: Survivors of head and neck cancer experience a negative impact on quality of life associated with trismus, hyposalivation, advanced stage tumors, and a younger patient age. The present findings underscore the importance of a specific approach focused on these aspects to ensure better quality of life in the long term.
Entities:
Keywords:
Head and neck cancer; Hyposalivation; Quality of life; Radiotherapy; Trismus
Authors: Michael K Ghiam; Kyle Mannion; Mary S Dietrich; Kristen L Stevens; Jill Gilbert; Barbara A Murphy Journal: Support Care Cancer Date: 2017-02-13 Impact factor: 3.603
Authors: Gustavo Nader Marta; Valter Silva; Heloisa de Andrade Carvalho; Fernando Freire de Arruda; Samir Abdallah Hanna; Rafael Gadia; João Luis Fernandes da Silva; Sebastião Francisco Miranda Correa; Carlos Eduardo Cintra Vita Abreu; Rachel Riera Journal: Radiother Oncol Date: 2013-12-13 Impact factor: 6.280
Authors: Susan Reisine; Douglas E Morse; Walter J Psoter; Ellen Eisenberg; Donald Cohen; Deborah Cleveland; Mirseyed Mohit-Tabatabai Journal: J Oral Maxillofac Surg Date: 2005-04 Impact factor: 1.895
Authors: Ilya Likhterov; Meng Ru; Cindy Ganz; Mark L Urken; Raymond Chai; Devin Okay; Jerry Liu; Robert Stewart; Bruce Culliney; Daisy Palacios; Cathy L Lazarus Journal: Laryngoscope Date: 2018-10-16 Impact factor: 3.325
Authors: A D Rapidis; P U Dijkstra; J L N Roodenburg; J P Rodrigo; A Rinaldo; P Strojan; R P Takes; A Ferlito Journal: Clin Otolaryngol Date: 2015-12 Impact factor: 2.597
Authors: Claudia R Albornoz; Andrea L Pusic; Patrick Reavey; Amie M Scott; Anne F Klassen; Stefan J Cano; Peter G Cordeiro; Evan Matros Journal: Clin Plast Surg Date: 2012-11-26 Impact factor: 2.017
Authors: Justin W G Roe; Michael J Drinnan; Paul N Carding; Kevin J Harrington; Christopher M Nutting Journal: Oral Oncol Date: 2014-10-14 Impact factor: 5.337
Authors: Herve Y Sroussi; Joel B Epstein; Rene-Jean Bensadoun; Deborah P Saunders; Rajesh V Lalla; Cesar A Migliorati; Natalie Heaivilin; Zachary S Zumsteg Journal: Cancer Med Date: 2017-10-25 Impact factor: 4.452
Authors: Andressa Silva de Freitas; Guilherme Maia Zica; Mariana Salles; Ana Catarina Alves E Silva; Thiago Huaytalla Silva; Fernando Luiz Dias; Izabella Costa Santos Journal: Int Arch Otorhinolaryngol Date: 2021-11-03
Authors: Marianne Boll Kristensen; Irene Wessel; Anne Marie Beck; Karin B Dieperink; Tina Broby Mikkelsen; Jens-Jakob Kjer Møller; Ann-Dorthe Zwisler Journal: Nutrients Date: 2020-07-17 Impact factor: 5.717
Authors: Marianne Boll Kristensen; Irene Wessel; Anne Marie Beck; Karin B Dieperink; Tina Broby Mikkelsen; Jens-Jakob Kjer Møller; Ann-Dorthe Zwisler Journal: Nutr J Date: 2020-03-17 Impact factor: 3.271